Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) is 22.47% higher on its value in year-to-date trading and has touched a low of $4.03 and a high of $9.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BCRX stock was last observed hovering at around $9.39 in the last trading session, with the day’s loss setting it -0.18%.
Currently trading at $9.21, the stock is 7.87% and 15.23% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.56 million and changing -1.92% at the moment leaves the stock 24.12% off its SMA200. BCRX registered 58.25% gain for a year compared to 6-month loss of 17.77%.
The stock witnessed a 20.87% gain in the last 1 month and extending the period to 3 months gives it a 30.45%, and is 4.42% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.25% over the week and 4.13% over the month.
Biocryst Pharmaceuticals Inc (BCRX) has around 536 employees, a market worth around $1.91B and $412.58M in sales. Profit margin for the company is -30.01%. Distance from 52-week low is 128.54% and -3.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-36.67%).
with sales reaching $130.05M over the same period.The EPS is expected to grow by 69.57% this year, but quarterly earnings will post 35.57% year-over-year. Quarterly sales are estimated to grow 39.23% in year-over-year returns.
Biocryst Pharmaceuticals Inc (BCRX) Top Institutional Holders
The shares outstanding are 207.12M, and float is at 195.41M with Short Float at 8.86%.
The top institutional shareholder in the company is BLACKROCK INC. with over 19.96 million shares valued at $123.33 million. The investor’s holdings represent 9.6845% of the BCRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 18.77 million shares valued at $$116.0 million to account for 9.1086 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 12.57 million shares representing 6.0894% and valued at over $77.68 million, while STATE STREET CORP holds 4.5279 of the shares totaling 9.35 million with a market value of $57.76 million.
Biocryst Pharmaceuticals Inc (BCRX) Insider Activity
The most recent transaction is an insider sale by Hutson Nancy J,the company’sDirector. SEC filings show that Hutson Nancy J sold 7,000 shares of the company’s common stock on Dec 13 ’24 at a price of $7.54 per share for a total of $52780.0. Following the sale, the insider now owns 86638.0 shares.
Still, SEC filings show that on Jun 24 ’24, McKee Amy E (Director) disposed off 8,600 shares at an average price of $6.32 for $54352.0. The insider now directly holds 27,831 shares of Biocryst Pharmaceuticals Inc (BCRX).
